These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 19639675)

  • 1. Ramelteon: application withdrawn. Ramelteon in insomnia: withdrawal of marketing application in patients' best interests.
    Prescrire Int; 2009 Jun; 18(101):114. PubMed ID: 19639675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ramelteon: new drug. Insomnia: no role for risky placebos.
    Prescrire Int; 2008 Oct; 17(97):183-6. PubMed ID: 19534018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.
    Pandi-Perumal SR; Srinivasan V; Poeggeler B; Hardeland R; Cardinali DP
    Nat Clin Pract Neurol; 2007 Apr; 3(4):221-8. PubMed ID: 17410109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ramelteon: a novel approach in the treatment of insomnia.
    Reynoldson JN; Elliott E; Nelson LA
    Ann Pharmacother; 2008 Sep; 42(9):1262-71. PubMed ID: 18648020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
    Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
    Mini LJ; Wang-Weigand S; Zhang J
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy.
    Spadoni G; Bedini A; Lucarini S; Mor M; Rivara S
    Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1145-56. PubMed ID: 25956235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ramelteon: a novel treatment for the treatment of insomnia.
    Wurtman R
    Expert Rev Neurother; 2006 Jul; 6(7):957-64. PubMed ID: 16831111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ramelteon for the treatment of insomnia.
    Borja NL; Daniel KL
    Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of ramelteon in Japanese adults with chronic insomnia: a randomized, double-blind, placebo-controlled study.
    Uchimura N; Ogawa A; Hamamura M; Hashimoto T; Nagata H; Uchiyama M
    Expert Rev Neurother; 2011 Feb; 11(2):215-24. PubMed ID: 21306209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ramelteon-induced nightmares: A case report.
    Shah C; Kablinger A
    Asian J Psychiatr; 2015 Dec; 18():111-2. PubMed ID: 26427581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ramelteon: a melatonin receptor agonist for the treatment of insomnia.
    Devi V; Shankar PK
    J Postgrad Med; 2008; 54(1):45-8. PubMed ID: 18296808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomnia.
    Uchiyama M; Hamamura M; Kuwano T; Nagata H; Hashimoto T; Ogawa A; Uchimura N
    Sleep Med; 2011 Feb; 12(2):127-33. PubMed ID: 21277255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New hypnotics ramelteon for the treatment of insomniacs with circadian rhythm disturbance].
    Mishima K
    Nihon Rinsho; 2012 Jun; 70(6):1069-78. PubMed ID: 22690618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation with ramelteon to achieve remission in geriatric major depression.
    Furuya M; Kunishige K; Miyaoka T; Wake R; Liaury K; Sadakuni F; Horiguchi J
    Psychiatry Clin Neurosci; 2012 Feb; 66(1):81-2. PubMed ID: 22250616
    [No Abstract]   [Full Text] [Related]  

  • 16. Ramelteon: a review of its therapeutic potential in sleep disorders.
    Pandi-Perumal SR; Srinivasan V; Spence DW; Moscovitch A; Hardeland R; Brown GM; Cardinali DP
    Adv Ther; 2009 Jun; 26(6):613-26. PubMed ID: 19568703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.
    Erman M; Seiden D; Zammit G; Sainati S; Zhang J
    Sleep Med; 2006 Jan; 7(1):17-24. PubMed ID: 16309958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia.
    Karim A; Tolbert D; Cao C
    J Clin Pharmacol; 2006 Feb; 46(2):140-8. PubMed ID: 16432265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A novel therapeutic drug: ramelteon].
    Miyamoto M
    Nihon Rinsho; 2009 Aug; 67(8):1595-600. PubMed ID: 19768947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ramelteon: profile of a new sleep-promoting medication.
    Owen RT
    Drugs Today (Barc); 2006 Apr; 42(4):255-63. PubMed ID: 16703122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.